title: Assessing the Potential for Drug-Nanoparticle Surface Interactions To Improve Drug Penetration into the Skin.
abstract: There is continued debate as to how nanomaterials enhance the passive diffusion of drugs through the skin. This study examined if drug-nanoparticle surface interactions, which occurred during topical application, had the capability to enhance percutaneous penetration. Atomic force microscopy force adhesion measurements were used to demonstrate that a model drug, tetracaine, strongly adsorbed to the surface of a negatively charged carboxyl-modified polystyrene nanoparticle (NanoPSCOOH) through both its methyl and amine functionalities (up to a 6- and 16-fold greater adhesion force respectively compared with the CH3-CH3 control). These drug-particle adhesion forces were significantly reduced (p < 0.05) to values that were lower than the CH3-CH3 control measurements when tetracaine interacted with a silica nanoparticle (NanoSiO2). This reduction in adhesion was attributed to the lower surface charge of the NanoSiO2 (ca. -23 mV) compared to the NanoPSCOOH (ca. -40 mV), which diminished the electrostatic interactions between positive amine of tetracaine and the negative particle. Mixing NanoPSCOOH with tetracaine on the skin retarded percutaneous drug penetration compared to the control (tetracaine saturated solution without nanoparticles), but the NanoSiO2, which still adsorbed the tetracaine, produced a 3.6-fold enhancement in percutaneous penetration compared to the same control. These data demonstrated the capability of moderate nanoparticle surface interactions that occurred within the application vehicle to promote drug percutaneous penetration.
authors.affiliation: Institute of Pharmaceutical Science, School of Life Sciences & Medicine, Franklin-Wilkins Building, Kings College London , London, SE1 9NH U.K.
authors.forename: X J
authors.initials: XJ
authors.lastname: Cai
authors.affiliation: Institute of Pharmaceutical Science, School of Life Sciences & Medicine, Franklin-Wilkins Building, Kings College London , London, SE1 9NH U.K.
authors.forename: A
authors.initials: A
authors.lastname: Woods
authors.affiliation: Institute of Pharmaceutical Science, School of Life Sciences & Medicine, Franklin-Wilkins Building, Kings College London , London, SE1 9NH U.K.
authors.forename: P
authors.initials: P
authors.lastname: Mesquida
authors.affiliation: Institute of Pharmaceutical Science, School of Life Sciences & Medicine, Franklin-Wilkins Building, Kings College London , London, SE1 9NH U.K.
authors.forename: S A
authors.initials: SA
authors.lastname: Jones
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods; D018625:Microscopy, Atomic Force; D053758:Nanoparticles / Q000737:chemistry*; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption; D013050:Spectrometry, Fluorescence; D013552:Swine; D013748:Tetracaine / Q000737:chemistry / Q000378:metabolism
chemical_list: D013748:Tetracaine
keywords: AFM; drug delivery; nanoparticles; penetration enhancement; skin; tetracaine; topical